Skip to main content
. 2020 Oct 21;21(20):7802. doi: 10.3390/ijms21207802
ICIs Immune checkpoint inhibitors
SGLT-2 Sodium-glucose cotransporter type-2
NLRP3 NOD-like receptor family pyrin domain, containing 3
MyD88 Myddosome type 88
PD1 Programmed cell death protein 1
PDL1 Programmed Death-Ligand 1
CTLA4 Cytotoxic T-Lymphocyte Antigen 4
AMPK 5’ AMP-activated protein kinase
hs-CRP High sensitivity C-reactive protein
ROS Reactive oxygen species
MDA Malondialdeyde
p65-NF-κB Nuclear factor kappa-light-chain-enhancer of activated B cells
ILs Interleukins
PDGF Platelet-Derived Growth Factor
VEGF Vascular endothelia growth factor
TGF-β Transforming growth factor beta
AGEs Advanced glycation end products
CVOTs Cardiovascular outcome trials
VEGF Vascular endothelia growth factor
TGF-β Transforming growth factor beta
AGEs Advanced glycation end products